Preferences
Related Series
Related Segments
Clinical Market Share 2011
Is Stimulus Money Still Stimulating?
After several years of lagging sales, the CIS market in U.S. hospitals over 200 beds largely rebounded in 2009, spurred by HITECH and the coveted meaningful use (MU) dollars. Heading into 2010, many wondered how long the boom would last—would the market continue its upward climb, level out, or fall back to pre-2009 levels? By independently validating vendor-claimed wins, KLAS investigated what happened in the CIS market in 2010. In the end, CIS sales in 2010 stayed at approximately the same level as sales in 2009. But which vendors are providers counting on to carry them through an ever-changing healthcare environment?
Project Manager
Robert Ellis
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.